Literature DB >> 15875133

Neuroprotective effects of anesthetic agents.

Masahiko Kawaguchi1, Hitoshi Furuya, Piyush M Patel.   

Abstract

Ischemic neuronal injury is characterized by early death mediated by excitotoxicity and by delayed death caused by apoptosis. Current evidence indicates that volatile agents, barbiturates, and propofol can protect neurons against ischemic injury caused by excitotoxicity. In the case of volatile agents and propofol, neuroprotection may be sustained if the ischemic insult is relatively mild; however, with moderate to severe insults, this neuronal protection is not sustained after a prolonged recovery period. This suggests that volatile agents and propofol do not reduce delayed neuronal death caused by apoptosis. The long-term effects of barbiturates on ischemic cerebral injury are not yet defined. Cerebral ischemia is characterized by continued neuronal loss for a long time after the initial ischemic insult. Therefore, in investigations of cerebral ischemia, the duration of the recovery period should be taken into consideration in the analysis of the neuroprotective effects of anesthetic agents. A combination of different approaches that target specific stages of the evolution of ischemic injury may be required for sustained neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875133     DOI: 10.1007/s00540-005-0305-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  47 in total

1.  Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage.

Authors:  Orhan Altay; Hidenori Suzuki; Bilge Nur Altay; Vahit Calisir; Jiping Tang; John H Zhang
Journal:  Neurosci Lett       Date:  2020-06-06       Impact factor: 3.046

Review 2.  Neuroprotection against surgically induced brain injury.

Authors:  Vikram Jadhav; Ihsan Solaroglu; Andre Obenaus; John H Zhang
Journal:  Surg Neurol       Date:  2007-01

Review 3.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

4.  Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

5.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

6.  Effect of mild and moderate hypothermia on hypoxic injury in nearly pure neuronal culture.

Authors:  Yu Hua; Kenjiro Hisano; Yuji Morimoto
Journal:  J Anesth       Date:  2010-08-05       Impact factor: 2.078

7.  Propofol increases expression of basic fibroblast growth factor after transient cerebral ischemia in rats.

Authors:  Xiao-Chun Zhao; Li-Min Zhang; Dong-Yi Tong; Ping An; Chao Jiang; Ping Zhao; Wei-Min Chen; Jian Wang
Journal:  Neurochem Res       Date:  2012-12-18       Impact factor: 3.996

8.  Anesthetic preconditioning inhibits isoflurane-mediated apoptosis in the developing rat brain.

Authors:  Jun Peng; Julie K Drobish; Ge Liang; Zhen Wu; Chunxia Liu; Donald J Joseph; Hossam Abdou; Maryellen F Eckenhoff; Huafeng Wei
Journal:  Anesth Analg       Date:  2014-10       Impact factor: 5.108

9.  Cerebral microembolization during primary total hip arthroplasty and neuropsychologic outcome: a pilot study.

Authors:  Rahul V Patel; Jan Stygall; Jane Harrington; Stanton P Newman; Fares S Haddad
Journal:  Clin Orthop Relat Res       Date:  2009-10-17       Impact factor: 4.176

10.  Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2010-04-02       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.